Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.14B | 5.42B | 5.23B | 5.13B | 5.13B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.14B | 5.42B | 5.23B | 5.13B | 5.13B |
| Cost of Revenue | 3.89B | 4.07B | 3.97B | 3.87B | 3.85B |
| Gross Profit | 1.25B | 1.35B | 1.26B | 1.26B | 1.27B |
| SG&A Expenses | 789.98M | 894.95M | 831.29M | 830.36M | 842.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 8.51M | -29.58M | -50.56M | -25.85M | -12.24M |
| Total Operating Expenses | 4.74B | 4.98B | 4.80B | 4.73B | 4.74B |
| Operating Income | 401.71M | 435.51M | 435.22M | 401.96M | 392.42M |
| Income Before Tax | 263.77M | 190.93M | 418.34M | 365.37M | 171.33M |
| Income Tax Expenses | 64.24M | 65.02M | 128.11M | 106.57M | 42.89M |
| Earnings from Continuing Operations | 199.53M | 125.91M | 290.23M | 258.80M | 128.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -40.40M | -54.60M | -56.03M | -57.49M | -51.41M |
| Net Income | 159.14M | 71.31M | 234.20M | 201.30M | 77.03M |
| EBIT | 401.71M | 435.51M | 435.22M | 401.96M | 392.42M |
| EBITDA | 804.33M | 650.65M | 837.42M | 667.33M | 813.34M |
| EPS Basic | 0.54 | 0.24 | 0.80 | 0.69 | 0.26 |
| Normalized Basic EPS | 0.63 | 0.65 | 0.61 | 0.52 | 0.50 |
| EPS Diluted | 0.54 | 0.23 | 0.80 | 0.69 | 0.26 |
| Normalized Diluted EPS | 0.63 | 0.65 | 0.61 | 0.52 | 0.50 |
| Average Basic Shares Outstanding | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M |
| Average Diluted Shares Outstanding | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M |
| Dividend Per Share | -- | 1.54 | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | 186.69% | -- |